Literature DB >> 16140962

Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect.

Nathalie Crokart1, Kim Radermacher, Bénédicte F Jordan, Christine Baudelet, Gregory O Cron, Vincent Grégoire, Nelson Beghein, Caroline Bouzin, Olivier Feron, Bernard Gallez.   

Abstract

We hypothesized that nonsteroidal antiinflammatory drugs (NSAIDs) might enhance tumor radiosensitivity by increasing tumor oxygenation (pO2), via either a decrease in the recruitment of macrophages or from inhibition of mitochondrial respiration. The effect of four NSAIDs (diclofenac, indomethacin, piroxicam, and NS-398) on pO2 was studied in murine TLT liver tumors and FSaII fibrosarcomas. At the time of maximum pO2 (t(max), 30 minutes after administration), perfusion, oxygen consumption, and radiation sensitivity were studied. Local pO2 measurements were done using electron paramagnetic resonance. Tumor perfusion and permeability measurements were assessed by dynamic contrast-enhanced magnetic resonance imaging. The oxygen consumption rate of tumor cells after in vivo NSAID administration was measured using high-frequency electron paramagnetic resonance. Tumor-infiltrating macrophage localization was done with immunohistochemistry using CD11b antibody. All the NSAIDs tested caused a rapid increase in pO2. At t(max), tumor perfusion decreased, indicating that the increase in pO2 was not caused by an increase in oxygen supply. Also at t(max), global oxygen consumption decreased but the amount of tumor-infiltrating macrophages remained unchanged. Our study strongly indicates that the oxygen effect caused by NSAIDs is primarily mediated by an effect on mitochondrial respiration. When irradiation (18 Gy) was applied at t(max), the tumor radiosensitivity was enhanced (regrowth delay increased by a factor of 1.7). These results show the potential utility of an acute administration of NSAIDs for radiosensitizing tumors, and shed new light on the mechanisms of NSAID radiosensitization. These results also provide a new rationale for the treatment schedule when combining NSAIDs and radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140962     DOI: 10.1158/0008-5472.CAN-05-1288

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

Review 1.  Molecular Pathways: A Novel Approach to Targeting Hypoxia and Improving Radiotherapy Efficacy via Reduction in Oxygen Demand.

Authors:  Alexander Lin; Amit Maity
Journal:  Clin Cancer Res       Date:  2015-05-01       Impact factor: 12.531

2.  Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.

Authors:  Na-Na Sun; Xiao-Lin Ge; Xi-Sheng Liu; Lu-Lu Xu
Journal:  Radiol Med       Date:  2019-10-11       Impact factor: 3.469

Review 3.  Mitochondria-targeted metformins: anti-tumour and redox signalling mechanisms.

Authors:  Balaraman Kalyanaraman; Gang Cheng; Micael Hardy; Olivier Ouari; Adam Sikora; Jacek Zielonka; Michael Dwinell
Journal:  Interface Focus       Date:  2017-04-06       Impact factor: 3.906

Review 4.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

5.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

6.  Characterization of response to radiation mediated gene therapy by means of multimodality imaging.

Authors:  Chad R Haney; Adrian D Parasca; Xiaobing Fan; Rebecca M Bell; Marta A Zamora; Gregory S Karczmar; Helena J Mauceri; Howard J Halpern; Ralph R Weichselbaum; Charles A Pelizzari
Journal:  Magn Reson Med       Date:  2009-08       Impact factor: 4.668

Review 7.  Optimal combination of antiangiogenic therapy for hepatocellular carcinoma.

Authors:  Hui-Ju Ch'ang
Journal:  World J Hepatol       Date:  2015-08-08

8.  Characterization of a clinically used charcoal suspension for in vivo EPR oximetry.

Authors:  Céline Marie Desmet; Ly Binh An Tran; Pierre Danhier; Bernard Gallez
Journal:  MAGMA       Date:  2018-09-12       Impact factor: 2.310

9.  Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.

Authors:  Gang Cheng; Jacek Zielonka; Olivier Ouari; Marcos Lopez; Donna McAllister; Kathleen Boyle; Christy S Barrios; James J Weber; Bryon D Johnson; Micael Hardy; Michael B Dwinell; Balaraman Kalyanaraman
Journal:  Cancer Res       Date:  2016-05-23       Impact factor: 12.701

Review 10.  Interfering with Tumor Hypoxia for Radiotherapy Optimization.

Authors:  Irma Telarovic; Roland H Wenger; Martin Pruschy
Journal:  J Exp Clin Cancer Res       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.